Back to search

Dante Genome House Ltd

13073074

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

86-90 PAUL STREET, LONDON, EC2A 4NE
Incorporated 09/12/2020

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Andrea Riposati

director · Since 09/12/2020

GENERAL MANAGER

ITALIAN · ENGLAND · Age 44

Also on 1 other board

Persons with Significant Control

Mr Andrea Riposati

50–75% shares
50–75% votes
Appoint directors

Italian · England · Age 44

86-90, Paul Street, London, EC2A 4NE

Notified 09/12/2020

Mr Mattia Capulli

25–50% shares
25–50% votes

Italian · Italy · Age 44

53, Via S Giuseppe 53, Pizzoli, 67017

Notified 09/12/2020

CompanyRankvs 1513+ SIC 72110 peers
52

Financial strength3th percentile among SIC peers · 1/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 5.1× · 20/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

-£1.5M

Balance sheet strength

Cash

£15

Cash in the bank

Net Current Assets

£427k

Working capital

Current Assets

£531k

Current Liabilities

£104k

Debtors

£531k

2avg. employees-2

Balance Sheet

Assets less current liabilities£3.0M
Signed by Company Registration No. 13073074Prepared with Comdal Limited - EasydigitalFiling.com

EstimatesDerived

YearCurrent RatioImplied Profit
20245.10-£4.2M
20236.01+£2.7M
20220.21

Derived from filed accounts. Not audited figures.